Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding.

Ghaida AlahmadiAzza M Y MaktabiGorka SesmaSaleh Almesfer

Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)

IVM is an effective treatment option for vitreous seeds. After 3 years of follow-up, the estimated survival rate for saved eyes decreased, and vitreous hemorrhage significantly increased the likelihood of enucleation. Further studies are required to determine the precise effects of IVM.

Keyphrases

vascular endothelial growth factor
combination therapy
free survival
endothelial cells
replacement therapy
smoking cessation
case control